Search research articles
Contact Us
Filters
Showing results (21-30 of 103) with videos related to
Page
of 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2003
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
S Cascinu, V Georgoulias, D Kerr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy
S Culine, M Fabbro, M Ychou, et al.
La Radiologia Medica
|
June 25, 2010
Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT
L Bacigalupo, S Aufort, M C Eberlé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 1999
Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid
J M Joulia, F Pinguet, M Ychou, et al.
Cancer Treatment Reviews
|
July 16, 2013
Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies
V Heinemann, M Reni, M Ychou, et al.
Bulletin Du Cancer
|
February 5, 1999
[Irinotecan in combination for colon cancer]
M Ducreux, M Gil-Delgado, T André, et al.
Annales De Chirurgie
|
January 1, 1989
[The value of tumor markers in digestive oncology]
M Ychou, P Rougier, J M Bidart, et al.
The British Journal of Dermatology
|
July 24, 2004
Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours
W Jacot, D Bessis, E Jorda, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 1999
Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer
F Bressolle, J M Joulia, F Pinguet, et al.
Anticancer Research
|
September 3, 1999
Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: a feasibility study in patients with advanced colorectal cancer
M Ychou, J Duffour, F Pinguet, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 103) with videos related to
Sort By:
Page
of 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2003
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
S Cascinu, V Georgoulias, D Kerr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy
S Culine, M Fabbro, M Ychou, et al.
La Radiologia Medica
|
June 25, 2010
Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT
L Bacigalupo, S Aufort, M C Eberlé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 1999
Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid
J M Joulia, F Pinguet, M Ychou, et al.
Cancer Treatment Reviews
|
July 16, 2013
Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies
V Heinemann, M Reni, M Ychou, et al.
Bulletin Du Cancer
|
February 5, 1999
[Irinotecan in combination for colon cancer]
M Ducreux, M Gil-Delgado, T André, et al.
Annales De Chirurgie
|
January 1, 1989
[The value of tumor markers in digestive oncology]
M Ychou, P Rougier, J M Bidart, et al.
The British Journal of Dermatology
|
July 24, 2004
Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours
W Jacot, D Bessis, E Jorda, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 1999
Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer
F Bressolle, J M Joulia, F Pinguet, et al.
Anticancer Research
|
September 3, 1999
Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: a feasibility study in patients with advanced colorectal cancer
M Ychou, J Duffour, F Pinguet, et al.
Page
of 11